- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Pharmaceutical revenue of Merck & Co. by segment 2018
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Pharmaceutical revenue of Merck & Co. by segment 2018
Pharmaceutical revenue of Merck & Co. in 2018, by segment (in million U.S. dollars)
This statistic shows the revenue of pharmaceutical and chemical company Merck KGaA in 2018, by segment. In that year, the company had a revenue of some 3.1 billion US. dollars in the hospital acute care segment.
Pharmaceutical revenue of Merck & Co. in 2018, by segment (in million U.S. dollars)
| Revenue in million U.S. dollars | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| Revenue in million U.S. dollars | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
This statistic shows the revenue of pharmaceutical and chemical company Merck KGaA in 2018, by segment. In that year, the company had a revenue of some 3.1 billion US. dollars in the hospital acute care segment.
Show more- Show sources information
- Show publisher information
- Release date
- February 2019
- Region
- Worldwide
- Survey time period
- 2018
- Supplementary notes
-
* These amounts do not reflect sales of vaccines sold in most major European markets through the Company’s joint venture, Sanofi Pasteur MSD, the results of which are reflected in Equity income from affiliates. These amounts do, however, reflect supply sales to Sanofi Pasteur MSD.
** Other pharmaceutical primarily reflects sales of other human health pharmaceutical products, including products within the franchises not listed separately. - Open this statistic in...
Source
- Show sources information
- Show publisher information
- Release date
- February 2019
More information
- Region
- Worldwide
- Survey time period
- 2018
- Supplementary notes
-
* These amounts do not reflect sales of vaccines sold in most major European markets through the Company’s joint venture, Sanofi Pasteur MSD, the results of which are reflected in Equity income from affiliates. These amounts do, however, reflect supply sales to Sanofi Pasteur MSD.
** Other pharmaceutical primarily reflects sales of other human health pharmaceutical products, including products within the franchises not listed separately. - Open this statistic in...
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Merck & Co.
- 50 page/s
- English
- pptx
- Detailed references
Everything On "Merck & Co." in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "Merck & Co."
- Global positioning
The most important statistics
- Top 10 global pharmaceutical companies based on pharma revenue in 2017 (in million U.S. dollars)Top global pharmaceutical companies based on pharma revenue 2017
- Top 10 global pharmaceutical and biotech companies based on total revenue in 2017 (in million U.S. dollars)Global leading pharma and biotech companies by total revenue in 2017
- Top 10 pharmaceutical companies based on global vaccine revenue market share in 2017 and 2024Leading pharmaceutical companies and total global vaccine market share 2017 and 2024
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2018 (in billion U.S. dollars)Top 10 biotech and pharmaceutical companies based on market cap 2018
- Overview
The most important statistics
- Total revenue of Merck & Co. from 2006 to 2018 (in million U.S. dollars)Merck & Co - total revenue 2006-2018
- Net income of Merck & Co. from 2006 to 2018 (in million U.S. dollars)Merck & Co.'s net income 2006-2018
- Total assets of Merck & Co. from 2009 to 2018 (in million U.S. dollars)Merck & Co. - total assets 2009-2018
- Capital expenditures of Merck & Co. from 2009 to 2018 (in million U.S. dollars)Merck & Co. capital expenditures 2009-2018
- Number of employees at Merck & Co. from 2008 to 2018*Merck & Co. number of employees 2008-2018
- Revenues
The most important statistics
- Top selling products of Merck & Co. based on revenue from 2016 to 2018 (in million U.S. dollars)Merck & Co.'s top-selling drugs 2016-2018
- Pharmaceutical revenue of Merck & Co. in 2018, by segment (in million U.S. dollars)Pharmaceutical revenue of Merck & Co. by segment 2018
- Revenues of Merck & Co. by region from 2012 to 2018 (in million U.S. dollars)Merck & Co. - revenues by region 2012-2018
- Expenses
The most important statistics
- Merck & Co.'s expenditure on research and development from 2006 to 2018 (in million U.S. dollars)Merck & Co - expenditure on research and development 2006-2018
- Merck & Co.'s selling, general and administrative expenses from 2014 to 2018 (in million U.S. dollars)Merck & Co SG&A expenses 2014-2018
- Materials and production expenses by Merck & Co. from 2009 to 2017 (in million U.S. dollars)Merck & Co. - costs of materials and production 2009-2017
- Marketing and administration expenses by Merck & Co. from 2009 to 2017 (in million U.S. dollars)Merck & Co. - costs of marketing and administration 2009-2017
- Shares/stockholders
The most important statistics
- Cash dividends declared by Merck & Co. from 2006 to 2018 (in million U.S. dollars)Merck & Co. - cash dividends declared 2006-2018
- Cash dividends per common share declared by Merck & Co. from 2009 to 2018 (in U.S. dollars)Merck & Co. - cash dividends per share declared 2009-2018
- Number of Merck & Co.'s common shares outstanding from 2009 to 2018 (in millions)Merck & Co. - average common outstanding shares 2009-2018
- Total number of Merck & Co.'s stockholders from 2009 to 2018*Merck & Co. - number of stockholders 2009-2018
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Merck KGaA's revenue by segment 2014-2018
- Sustainability in the pharmaceutical and chemical industry
- Number of orphan drugs used in Norway 2016-2018
- Pharmacy market sales' parallel import share - European countries 2016
- China's pharmaceutical market distribution 2011
- Chile: retail market volume of pharmaceutical product sales 2015-2017
- Members of EFPIA's pharmaceutical exports and imports 1990-2017
- U.S. human and veterinary pharmaceuticals - R&D spending 2017
- Number of orphan drugs used in Denmark 2008-2018
- Brazil: Ultrafarma's advertising spending 2016-2017
- Projected 2020 revenue for top drugs approved in U.S. 2015
- Willingness of Chinese consumers to pay more for international medicine brands 2013
- Pharmaceutical industry forecast
- U.S. pharmaceutical industry spending on research and development 1990-2017
- Brazil: Hypera Pharma's ad spending H1 2016-2017
- Sales value of agents acting on the musculo-skeletal system in Spain 2004-2015
- Most important subsidized drugs prescribed by optometrists 2015
- Main exporters of pharmaceutical products to the United Kingdom (UK) 2016-2017
- Value of pharmaceutical sales in Slovakia 2000-2016
- United Kingdom (UK): pharmaceutical products import value from Belgium 2012-2017
Studies
- Pharmaceutical industry in Italy
- Pharmaceutical trends in Europe
- Sobi Anual and sustainability report 2017
- Teva - 2018 Form 10-K
- Biotechnology in Germany
- Indicatori Farmaceutici
- Pharmaceutical industry in the Netherlands
- Novo Nordisk ANNUAL REPORT 2017
- Celgene Corporation - 2018 Form 10-K
- Biogen Inc. - 2018 Form 10-K
- Gilead Sciences - 2018 Form 10-K
- 2018 PhRMA Annual Membership Survey
- Boehringer Ingelheim - Annual Report 2017
- The 2018 Genentech Oncology Trend Report
- PAGB Annual Review 2017-2018
Statistics on "Merck & Co."
- Top 10 global pharmaceutical companies based on pharma revenue in 2017 (in million U.S. dollars)
- Top 10 global pharmaceutical and biotech companies based on total revenue in 2017 (in million U.S. dollars)
- Top 10 pharmaceutical companies based on global vaccine revenue market share in 2017 and 2024
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2018 (in billion U.S. dollars)
- Total revenue of Merck & Co. from 2006 to 2018 (in million U.S. dollars)
- Net income of Merck & Co. from 2006 to 2018 (in million U.S. dollars)
- Total assets of Merck & Co. from 2009 to 2018 (in million U.S. dollars)
- Capital expenditures of Merck & Co. from 2009 to 2018 (in million U.S. dollars)
- Number of employees at Merck & Co. from 2008 to 2018*
- Top selling products of Merck & Co. based on revenue from 2016 to 2018 (in million U.S. dollars)
- Pharmaceutical revenue of Merck & Co. in 2018, by segment (in million U.S. dollars)
- Revenues of Merck & Co. by region from 2012 to 2018 (in million U.S. dollars)
- Merck & Co.'s expenditure on research and development from 2006 to 2018 (in million U.S. dollars)
- Merck & Co.'s selling, general and administrative expenses from 2014 to 2018 (in million U.S. dollars)
- Materials and production expenses by Merck & Co. from 2009 to 2017 (in million U.S. dollars)
- Marketing and administration expenses by Merck & Co. from 2009 to 2017 (in million U.S. dollars)
- Cash dividends declared by Merck & Co. from 2006 to 2018 (in million U.S. dollars)
- Cash dividends per common share declared by Merck & Co. from 2009 to 2018 (in U.S. dollars)
- Number of Merck & Co.'s common shares outstanding from 2009 to 2018 (in millions)
- Total number of Merck & Co.'s stockholders from 2009 to 2018*
- Merck KGaA's revenue from 2014 to 2018, by segment (in million euros)*
- Sustainability in the pharmaceutical and chemical industry in 2009 by benchmarks (in percent)
- Number of orphan drugs used in Norway from 2016 to 2018
- Share of parallel imports in pharmacy market sales in selected European countries in 2016
- China's pharmaceutical market distribution in 2011
- Retail sales volume of pharmaceutical products in Chile from 2015 to 2017 (in 1,000 units)
- Pharmaceutical imports and exports of EFPIA members from 1990 to 2017 (in million euros)
- Spending on human and veterinary pharmaceutical R&D in the U.S. in 2017 (in million U.S. dollars)
- Number of orphan drugs used in Denmark from 2008 to 2018
- Advertising spending of Ultrafarma in Brazil in 1st half 2016 and 2017 (in million Brazilian reals)
- Projected 2020 revenue for top drugs approved in the U.S. in 2015 (in billion U.S. dollars)
- Willingness of Chinese consumers to pay extra for international medicine brands in 2013
- Forecasts for leading pharmaceutical companies in 2011*
- Spending of the U.S. pharmaceutical industry on research and development at home and abroad from 1990 to 2017 (in million U.S. dollars)*
- Advertising spending of Hypera Pharma in Brazil in 1st half 2016 and 2017 (in million Brazilian reals)
- Total sales value of agents acting on the musculo-skeletal system in Spain from 2004 to 2015 (in million euros)
- Leading subsidized drugs that are most often prescribed by optometrists in Australia in 2015, by total cost* (in Australian dollars)
- Main countries exporting pharmaceutical products to the United Kingdom (UK) in 2016 and 2017 (in thousand British pounds)
- Total value of pharmaceutical sales in Slovakia from 2000 to 2016 (in million euro)
- Value of pharmaceutical products imported into the United Kingdom (UK) from Belgium from 2012 to 2017 (in million U.S. dollars)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.